PATENT CLAIM ANALYSIS

Application Number: 16044653
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["544", "281000"]

Abstract:
Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Claim (Index 11):
The method of  claim 2 , wherein the Trk kinase is TrkA and TrkB.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.13636
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14846166', '14490460', '15399389', '15860948', '13943590']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8029210867086146
- 35 USC 102 Novelty (BERT): 0.6120081300153509
- Combined Prediction Score: 0.7838297910392883
- Mean Citation Score: 516.280366
- Max Citation Score: 538.1641
- Similarity Product: 511.1396733237028

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test